MindMed | Investor Day Presentation Deck

Slide schematic 6/6

image 1/1 list 2/2 paragraph 1/1 subtitle 1/1 title 1/1

Components 6

screenshot bullet bullet paragraph subtitle headline

Tools 1

Problem Statement Canvas slide · 70%

We are positioned for two key data readouts this year and have recently reached an enrollment milestone in our Phase 2b trial for GAD with over 50% of patients dosed across 20 active clinical sites

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Includes a screenshot of a press release as evidence of the enrollment milestone.